Literature DB >> 18634419

[Successful steroid pulse therapy for acute unilateral oculomotor nerve palsy associated with norovirus infection].

Ichiro Kuki1, Hisashi Kawawaki, Shin Okazaki, Hiroko Ikeda, Kiyotaka Tomiwa.   

Abstract

We report a 4-year-old boy who developed acute unilateral oculomotor nerve palsy following Norovirus infection. He visited our hospital because of diplopia three weeks after Norovirus gastroenteritis. Physical examination showed only the left oculomotor nerve palsy. Enhanced MRI of the brain and cerebrospinal fluid examination revealed no abnormality. Anti GQlb antibody was negative. Because blepharoptosis and ophthalmoplegia progressed rapidly, we performed three courses of steroid pulse therapy (methylpredonisolone 30 mg/kg x 3 day/course) combined with vitamin B6. Autonomic dysfunction (isocorea, light reflex) began to improve in several days and subsequently extraocular movements (blepharoptosis, infraduction supraduction, adducent in order) resolved completely in one month. Idiopathic oculomotor paralysis is usually believed to be selflimited, but steroid pulse therapy should to be considered in cases ocular paralysis is so severe or progressive that immune-mediated mechanism was presumed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18634419

Source DB:  PubMed          Journal:  No To Hattatsu        ISSN: 0029-0831


  3 in total

1.  Steroids in the Management of Synkinesis after Traumatic Oculomotor Palsy in India.

Authors:  Peter W MacIntosh; Virna Shah
Journal:  Neuroophthalmology       Date:  2017-09-14

2.  Viral mononeurities causing partial oculomotor nerve palsy in an 8 month old child.

Authors:  Jayitri Mazumdar; Chandana Chakraborti; Arundhati Banerjee; Mousumi Nandi
Journal:  Oman J Ophthalmol       Date:  2017 May-Aug

3.  Acute isolated medial rectus palsy due to infarction as a result of hypercoagulable state: A case report and literature review.

Authors:  Arvind K Morya; Kalpit Jangid; Anushree Naidu; Sahil Bhandari; Sujeet Prakash; Sonalika Gogia
Journal:  Indian J Ophthalmol       Date:  2019-11       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.